Comparative serum proteome analysis of human lymph node negative/positive invasive ductal carcinoma of the breast and benign breast disease controls via label-free semiquantitative shotgun technology

OMICS A Journal of Integrative Biology

Volumn 13, Issue 4, 2009, Pages 291-300

  Hu, Xiaofang ^a   Zhang, Yan ^a   Zhang, Aili ^a   Li, Yingzi ^a   Zhu, Zhenmin ^a   Shao, Zhimin ^b   Zeng, Rong ^c   Xu, Lisa X ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

^c Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; ANKYRIN; ANTITHROMBIN III; APOLIPOPROTEIN A; APOLIPOPROTEIN A5; APOLIPOPROTEIN C1; APOLIPOPROTEIN C2; APOLIPOPROTEIN M; BLOOD CLOTTING FACTOR 10; CARBOXYPEPTIDASE; CERULOPLASMIN; COMPLEMENT COMPONENT C1Q; COMPLEMENT COMPONENT C5; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C9; FETUIN A; FIBRINOGEN; GELSOLIN; GLYCOPROTEIN; GLYCOPROTEIN IB ALPHA; HEMOPEXIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAIN; LUMICAN; MIMECAN; PROTEIN SH3; PROTEOME; TENASCIN; THYROID HORMONE RECEPTOR; VITAMIN D BINDING PROTEIN;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST DISEASE; BREAST DUCT; BREAST METASTASIS; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; INVASIVE CARCINOMA; LIQUID CHROMATOGRAPHY; LYMPH NODE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; TANDEM MASS SPECTROMETRY;

ADULT; BREAST DISEASES; BREAST NEOPLASMS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, LIQUID; CLUSTER ANALYSIS; COMPUTATIONAL BIOLOGY; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; PROTEOME; PROTEOMICS; TANDEM MASS SPECTROMETRY; TUMOR MARKERS, BIOLOGICAL;

EID: 69249117412     PISSN: 15362310     EISSN: None     Source Type: Journal    
DOI: 10.1089/omi.2009.0016     Document Type: Article

References (47)

1. Abbott, K.L., Aoki, K., Lim, J.M., Porterfield, M., Johnson, R., O'Regan, R.M. et al. (2008). Targeted glycoproteomic identification of biomarkers for human breast carcinoma. J Proteome Res 7, 1470-1480.
2. Alldridge, L., Metodieva, G., Greenwood, C., Al-Janabi, K., Thwaites, L., Sauven, P. et al. (2008). Proteome profiling of breast tumors by gel electrophoresis and nanoscale electrospray ionization mass spectrometry. J Proteome Res 7, 1458-1469.
3. Antman, K., and Shea, S. (1999). Screening mammography under age 50. JAMA 281, 1470-1472.
4. Bristow, J., Tee, M.K., Gitelman, S.E., Mellon, S.H., and Miller, W.L. (1993). Tenascin-X: a novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B. J Cell Biol 122, 265-278.
5. Burch, G.H., Gong, Y., Liu, W., Dettman, R.W., Curry, C.J., Smith, L., et al. (1997). Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat Genet 17, 104-108.
6. Catanese, J.J., and Kress, L.F. (1992). Isolation from opossum serum of a metalloproteinase inhibitor homologous to human alpha 1B-glycoprotein. Biochemistry 31, 410-418.
7. Colantonio, D.A., Dunkinson, C., Bovenkamp, D.E., and Van Eyk, J.E. (2005). Effective removal of albumin from serum. Proteomics 5, 3831-3835.
8. Esserman, L., Cowley, H., Eberle, C., Kirkpatrick, A., Chang, S., Berbaum, K., et al. (2002). Improving the accuracy of mammography: volume and outcome relationships. J Natl Cancer Inst 94, 369-375.
9. Fukunaga, M. (2002). Gastric carcinoma resembling pancreatic mixed acinar-endocrine carcinoma. Hum Pathol 33, 569-573.
10. Goncalves, A., Esterni, B., Bertucci, F., Sauvan, R., Chabannon, C., Cubizolles, M., et al. (2006). Postoperative serum proteomic profiles may predict metastatic relapse in high-risk primary breast cancer patients receiving adjuvant chemotherapy. Oncogene 25, 981-989.
11. Gromov, P., Celis, J.E., Gromova, I., Rank, F., Timmermans-Wielenga, V., and Moreira, J.M. (2008). A single lysis solution for the analysis of tissue samples by different proteomic technologies. Mol Oncol 2, 368-379.
12. Harrell, J.C., Dye, W.W., Harvell, D.M., Sartorius, C.A., and Horwitz, K.B. (2008). Contaminating cells alter gene signatures in whole organ versus laser capture microdissected tumors: a comparison of experimental breast cancers and their lymph node metastases. Clin Exp Metastasis 25, 81-88.
13. Harris, L., Fritsche, H., Mennel, R., Norton, L., Ravdin, P., Taube, S., et al. (2007). American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25, 5287-5312.
14. Hasegawa, K., Yoshida, T., Matsumoto, K., Katsuta, K., Waga, S., and Sakakura. T. (1997). Differential expression of tenascin-C and tenascin-X in human astrocytomas. Acta Neuropathol 93, 431-437.
15. Higashiyama, M., Doi, O., Yokouchi, H., Kodama, K., Nakamori, S., and Tateishi, R. (1995). Alpha-1-antichymotrypsin expression in lung adenocarcinoma and its possible association with tumor progression. Cancer 76, 1368-1376.
16. Huang, H.L., Stasyk, T., Morandell, S., Dieplinger, H., Falkensammer, G., Griesmacher, A., et al. (2006). Biomarker discovery in breast cancer serum using 2-D differential gel electrophoresis/MALDI-TOF/TOF and data validation by routine clinical assays. Electrophoresis 27, 1641-1650.
17. Ikuta, T., Sogawa, N., Ariga, H., Ikemura, T., and Matsumoto, K. (1998). Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family. Gene 217, 1-13.
18. Issaq, H.J., Xiao, Z., and Veenstra, T.D. (2007). Serum and plasma proteomics. Chem Rev 107, 3601-3620.
19. Jemal,A., Tiwari, R.C.,Murray, T.,Ghafoor,A., Samuels,A.,Ward, E., et al. (2004). Cancer statistics, 2004. CACancer J Clin 54, 8-29.
20. Kelsey, J.L., and Berkowitz, G.S. (1988). Breast cancer epidemiology. Cancer Res 48, 5615-5623.
21. Kreunin, P., Zhao, J., Rosser, C., Urquidi, V., Lubman, D.M., and Goodison, S. (2007). Bladder cancer associated glycoprotein signatures revealed by urinary proteomic profiling. J Proteome Res 6, 2631-2639.
22. Kulasingam, V., and Diamandis, E.P. (2007). Proteomics analysis of conditioned media from three breast cancer cell lines: a mine for biomarkers and therapeutic targets. Mol Cell Proteomics 6, 1997-2011.
23. Levy, P., Ripoche, H., Laurendeau, I., Lazar, V., Ortonne, N., Parfait, B., et al. (2007). Microarray-based identification of tenascin C and tenascin XB, genes possibly involved in tumorigenesis associated with neurofibromatosis type 1. Clin Cancer Res 13, 398-407.
24. Lilja, H., Christensson, A., Dahlen, U., Matikainen, M.T., Nilsson, O., Pettersson, K., et al. (1991). Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin. Clin Chem 37, 1618-1625.
25. LUmachi, F., and Basso, S.M. (2004). Serum tumor markers in patients with breast cancer. Expert Rev Anticancer Ther 4, 921-931.
26. Matsumoto, K., Takayama, N., Ohnishi, J., Ohnishi, E., Shirayoshi, Y., Nakatsuji, N., et al. (2001). Tumour invasion and metastasis are promoted in mice deficient in tenascin-X. Genes Cells 6, 1101-1111.
27. Maurya, P., Meleady, P., Dowling, P., and Clynes, M. (2007). Proteomic approaches for serum biomarker discovery in cancer. Anticancer Res 27, 1247-1255.
28. Mbeunkui, F., Metge, B.J., Shevde, L.A., and Pannell, L.K. (2007). Identification of differentially secreted biomarkers using LCMS/MS in isogenic cell lines representing a progression of breast cancer. J Proteome Res 6, 2993-3002.
29. McDonald, W.H., and Yates, J.R., 3rd. (2002). Shotgun proteomics and biomarker discovery. Dis Markers 18, 99-105.
30. Miller, J.C., Zhou, H., Kwekel, J., Cavallo, R., Burke, J., Butler, E.B., et al. (2003). Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3, 56-63.
31. Mincey, B.A., and Perez, E.A. (2004). Advances in screening, diagnosis, and treatment of breast cancer. Mayo Clin Proc 79, 810-816.
32. Old, W.M., Meyer-Arendt, K., Aveline-Wolf. L., Pierce, K.G., Mendoza, A., Sevinsky, J.R., et al. (2005). Comparison of labelfree methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 4, 1487-1502.
33. Othman, M.I., Majid, M.I., Singh, M., Man, C.N., and Lay-Harn, G. (2008). Isolation, identification and quantification of differentially expressed proteins from cancerous and normal breast tissues. Ann Clin Biochem 45, 299-306.
34. Pan, J., Chen, H.Q., Sun, Y.H., Zhang, J.H., and Luo, X.Y. (2008). Comparative proteomic analysis of non-small-cell lung cancer and normal controls using serum label-free quantitative shotgun technology. Lung 186, 255-261.
35. Pitteri, S.J., Faca, V.M., Kelly-Spratt, K.S., Kasarda, A.E., Wang, H., Zhang, Q., et al. (2008). Plasma proteome profiling of a mouse model of breast cancer identifies a set of up-regulated proteins in common with human breast cancer cells. J Proteome Res 7, 1481-1489.
36. Rai, A.J., Gelfand, C.A., Haywood, B.C., Warunek, D.J., Yi, J., Schuchard, M.D., et al. (2005). HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics 5, 3262-3277.
37. Rompp, A., Dekker, L., Taban, I., Jenster, G., Boogerd, W., Bonfrer, H., et al. (2007). Identification of leptomeningeal metastasis-related proteins in cerebrospinal fluid of patients with breast cancer by a combination of MALDI-TOF, MALDIFTICR and nanoLC-FTICR MS. Proteomics 7, 474-481.
38. Rosenblatt, K.P., Bryant-Greenwood, P., Killian, J.K., Mehta, A., Geho, D., Espina, V., et al. (2004). Serum proteomics in cancer diagnosis and management. Annu Rev Med 55, 97-112.
39. Rothemund, D.L., Locke, V.L., Liew, A., Thomas, T.M., Wasinger, V., and Rylatt, D.B. (2003). Depletion of the highly abundant protein albumin from human plasma using the Gradiflow. Proteomics 3, 279-287.
40. Ru, Q.C., Zhu, L.A., Silberman, J., and Shriver, C.D. (2006). Label-free semiquantitative peptide feature profiling of human breast cancer and breast disease sera via two-dimensional liquid chromatography-mass spectrometry. Mol Cell Proteomics 5, 1095-1104.
41. Sjoblom, T., Jones, S., Wood, L.D., Parsons, D.W., Lin, J., Barber, T.D. et al. (2006). The consensus coding sequences of human breast and colorectal cancers. Science 314, 268-274.
42. Somiari, R.I., Sullivan, A., Russell, S., Somiari, S., Hu, H., Jordan, R., et al. (2003). High-throughput proteomic analysis of human infiltrating ductal carcinoma of the breast. Proteomics 3, 1863-1873.
43. Tian, M., Cui, Y.Z., Song, G.H., Zong, M.J., Zhou, X.Y., Chen, Y., et al. (2008). Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients. BMC Cancer 8, 241.
44. Yamamura, J., Miyoshi, Y., Tamaki, Y., Taguchi, T., Iwao, K., Monden, M., et al. (2004). mRNA expression level of estrogeninducible gene, alpha 1-antichymotrypsin, is a predictor of early tumor recurrence in patients with invasive breast cancers. Cancer Sci 95, 887-892.
45. Yang, Z., Harris, L.E., Palmer-Toy, D.E., and Hancock, W.S. (2006). Multilectin affinity chromatography for characterization of multiple glycoprotein biomarker candidates in serum from breast cancer patients. Clin Chem 52, 1897-1905.
46. Yoon, S.Y., Kim, J.M., Oh, J.H., Jeon, Y.J., Lee, D.S., Kim, J.H., et al. (2006). Gene expression profiling of human HBV- and/or HCV-associated hepatocellular carcinoma cells using expressed sequence tags. Int J Oncol 29, 315-327.
47. Zhu, Z.M., Hu, X.F., and Zeng, R. (2007). [Application of serum proteomics in breast cancer research]. Zhonghua Zhong Liu Za Zhi 29, 561-565.